759 filings
EFFECT
KPRX
Kiora Pharmaceuticals Inc
29 Mar 24
Notice of effectiveness
12:15am
424B3
KPRX
Kiora Pharmaceuticals Inc
28 Mar 24
Prospectus supplement
4:48pm
DEF 14A
KPRX
Kiora Pharmaceuticals Inc
Definitive proxy
25 Mar 24
4:32pm
8-K
KPRX
Kiora Pharmaceuticals Inc
25 Mar 24
Results of Operations and Financial Condition
7:03am
10-K
2023 FY
KPRX
Kiora Pharmaceuticals Inc
Annual report
25 Mar 24
7:01am
PRE 14A
KPRX
Kiora Pharmaceuticals Inc
Preliminary proxy
15 Mar 24
7:00am
S-3
KPRX
Kiora Pharmaceuticals Inc
Shelf registration
28 Feb 24
4:40pm
SC 13G/A
Lincoln Park Capital Fund, LLC
14 Feb 24
KIORA PHARMACEUTICALS / Lincoln Park Capital Fund ownership change
4:55pm
D
KPRX
Kiora Pharmaceuticals Inc
14 Feb 24
$15.00 mm in equity / options / securities to be acquired, sold $15.00 mm, 13 investors
3:51pm
SC 13G/A
Lind Global Fund II LP
13 Feb 24
KIORA PHARMACEUTICALS / Lind Global Fund II ownership change
8:08pm
8-K
KPRX
Kiora Pharmaceuticals Inc
12 Feb 24
Regulation FD Disclosure
5:23pm
SC 13G
Stonepine Capital Management, LLc
9 Feb 24
KIORA PHARMACEUTICALS / Stonepine Capital Management ownership change
4:16pm
SC 13G
KPRX
Kiora Pharmaceuticals Inc
7 Feb 24
KIORA PHARMACEUTICALS / HIRSCHMAN ORIN ownership change
9:22am
SC 13G/A
KPRX
Kiora Pharmaceuticals Inc
6 Feb 24
KIORA PHARMACEUTICALS / INTRACOASTAL CAPITAL ownership change
10:27am
8-K
KPRX
Kiora Pharmaceuticals Inc
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
KPRX
Kiora Pharmaceuticals Inc
31 Jan 24
Entry into a Material Definitive Agreement
5:14pm
8-K
KPRX
Kiora Pharmaceuticals Inc
16 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
KPRX
Kiora Pharmaceuticals Inc
9 Nov 23
Regulation FD Disclosure
7:02am
8-K
KPRX
Kiora Pharmaceuticals Inc
9 Nov 23
Results of Operations and Financial Condition
7:01am
10-Q
2023 Q3
KPRX
Kiora Pharmaceuticals Inc
Quarterly report
9 Nov 23
7:00am